相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis
Dana Lukin et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Risk of Serious Infections With Vedolizumab Versus Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease
Julien Kirchgesner et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease
Fabio Salvatore Macaluso et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
First- and Second-Line Pharmacotherapies for Patients With Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis
Joseph D. Feuerstein et al.
GASTROENTEROLOGY (2020)
AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis
Siddharth Singh et al.
GASTROENTEROLOGY (2020)
Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease
Matthew Bohm et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Overall and comparative safety of biologic and immunosuppressive therapy in inflammatory bowel diseases
Ariela Holmer et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2019)
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
Bruce E. Sands et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Systematic review and network meta-analysis: first- and second-line biologic therapies for moderate-severe Crohn's disease
S. Singh et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-Up in the Pyramid Registry
Geert D'Haens et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases
Julien Kirchgesner et al.
GASTROENTEROLOGY (2018)
Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study
Thomas Gilbert et al.
LANCET (2018)
Comparison of infliximab with adalimumab in 827 biologic-naive patients with Crohn's disease: a population-based Danish cohort study
S. Singh et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
The safety of vedolizumab for ulcerative colitis and Crohn's disease
Jean-Frederic Colombel et al.
GUT (2017)
Comparison of Infliximab and Adalimumab in Biologic-Naive Patients With Ulcerative Colitis: A Nationwide Danish Cohort Study
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Comparative Effectiveness and Safety of Anti-Tumor Necrosis Factor Agents in Biologic-Naive Patients With Crohn's Disease
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis
Stefanos Bonovas et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial results
Tim Wyant et al.
GUT (2015)
Optum Labs: Building A Novel Node In The Learning Health Care System
Paul J. Wallace et al.
HEALTH AFFAIRS (2014)
Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry
Gary R. Lichtenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Administrative codes combined with medical records based criteria accurately identified bacterial infections among rheumatoid arthritis patients
Nivedita M. Patkar et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Constructing inverse probability weights for marginal structural models
Stephen R. Cole et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Computerized definitions showed high positive predictive values for identifying hospitalizations for congestive heart failure and selected infections in Medicaid enrollees with rheumatoid arthritis
Carlos G. Grijalva et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
分享论文
